HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Osamu Watanabe Selected Research

7-nitrobenzo-2-oxa-1,3-diazole chloride

1/2017Inhibition of KDM4A activity as a strategy to suppress interleukin-6 production and attenuate colitis induction.
9/2010Novel mouse model of colitis characterized by hapten-protein visualization.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Osamu Watanabe Research Topics

Disease

15Neoplasms (Cancer)
01/2016 - 01/2002
12Isaacs Syndrome (Neuromyotonia)
12/2018 - 01/2002
9Breast Neoplasms (Breast Cancer)
09/2021 - 01/2002
8Hemorrhage
01/2018 - 11/2008
7Neoplasm Metastasis (Metastasis)
03/2019 - 01/2002
7Crohn Disease (Crohn's Disease)
05/2018 - 12/2008
7Limbic Encephalitis (Paraneoplastic Limbic Encephalitis)
03/2017 - 04/2010
7Colitis
01/2017 - 02/2007
6Pathologic Constriction (Stenosis)
12/2018 - 01/2015
6Infections
03/2016 - 10/2005
5Seizures (Absence Seizure)
11/2021 - 11/2013
5Pain (Aches)
09/2021 - 01/2012
5Glioma (Gliomas)
12/2018 - 01/2015
5Ulcerative Colitis
01/2015 - 02/2005
4Epilepsy (Aura)
11/2021 - 04/2010
4Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease)
04/2018 - 10/2012
4Amnesia (Dissociative Amnesia)
04/2018 - 11/2013
4Channelopathies
01/2018 - 01/2002
4Autoimmune limbic encephalitis
03/2017 - 01/2013
4Encephalitis (Encephalitis, Rasmussen)
11/2016 - 02/2012
4Ulcer
03/2016 - 10/2005
4Stomach Neoplasms (Stomach Cancer)
12/2014 - 12/2008
3Thymoma (Thymic Carcinoma)
12/2018 - 02/2012
3Autonomic Nervous System Diseases (Dysautonomia)
04/2018 - 01/2013
3Muscle Cramp (Cramp)
04/2018 - 04/2016
3Sleep Initiation and Maintenance Disorders (Insomnia)
04/2018 - 01/2013
3Brain Diseases (Brain Disorder)
04/2018 - 09/2016
3POEMS Syndrome (Syndrome, POEMS)
10/2016 - 06/2008
3Inflammation (Inflammations)
01/2016 - 02/2007
3Inappropriate ADH Syndrome (SIADH)
01/2014 - 01/2013
3Nervous System Diseases (Neurological Disorders)
11/2013 - 06/2008
3Carcinoma (Carcinomatosis)
11/2010 - 03/2002
3Carcinogenesis
11/2004 - 04/2003
2Drowning
09/2019 - 03/2019
2Pancreatic Neoplasms (Pancreatic Cancer)
12/2018 - 03/2016
2Psychotic Disorders (Schizoaffective Disorder)
04/2018 - 09/2016
2Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
04/2018 - 04/2013
2Polyps
04/2017 - 12/2010
2Fever (Fevers)
10/2016 - 11/2014
2Ileus
10/2016 - 01/2015
2Heart Failure
10/2016 - 08/2012
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
10/2016 - 02/2005
2Fibrosis (Cirrhosis)
10/2016 - 08/2012
2Paraproteinemias (Monoclonal Gammopathy)
10/2016 - 01/2015
2Cognitive Dysfunction
04/2016 - 06/2014
2Muscle Weakness
03/2016 - 01/2014
2Disease Progression
01/2015 - 01/2014
2Autoimmune Diseases of the Nervous System
01/2015 - 06/2014
2Paralysis (Palsy)
01/2014 - 01/2011
2Body Weight (Weight, Body)
10/2013 - 09/2010
2Myasthenia Gravis
02/2012 - 09/2011
2Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
03/2011 - 01/2009

Drug/Important Bio-Agent (IBA)

18Proteins (Proteins, Gene)FDA Link
12/2018 - 10/2005
17AntibodiesIBA
12/2018 - 09/2004
14Capsules (Microcapsules)IBA
01/2018 - 01/2009
10Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA
12/2018 - 09/2004
9AutoantibodiesIBA
12/2018 - 06/2008
5Leucine (L-Leucine)FDA Link
12/2018 - 01/2015
5CytokinesIBA
10/2016 - 02/2007
4Anticonvulsants (Antiepileptic Drugs)IBA
11/2021 - 01/2012
4Paclitaxel (Taxol)FDA LinkGeneric
03/2019 - 01/2002
4SteroidsIBA
11/2016 - 06/2008
4Epirubicin (Ellence)FDA LinkGeneric
11/2010 - 01/2006
3AntigensIBA
12/2018 - 03/2016
3Biomarkers (Surrogate Marker)IBA
05/2018 - 04/2014
3AMPA Receptors (AMPA Receptor)IBA
04/2018 - 11/2013
3PotassiumIBA
01/2018 - 01/2002
3InterleukinsIBA
01/2017 - 02/2005
3Interleukin-6 (Interleukin 6)IBA
01/2017 - 01/2009
3HaptensIBA
01/2017 - 09/2010
3Pharmaceutical PreparationsIBA
11/2016 - 05/2013
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2016 - 06/2008
3Surface Antigens (Surface Antigen)IBA
04/2016 - 11/2013
3Adrenal Cortex Hormones (Corticosteroids)IBA
03/2016 - 02/2007
3Potassium Channels (Potassium Channel)IBA
01/2013 - 01/2002
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2010 - 05/2004
3Docetaxel (Taxotere)FDA Link
11/2008 - 01/2002
2SaltsIBA
09/2019 - 03/2019
27-nitrobenzo-2-oxa-1,3-diazole chlorideIBA
01/2017 - 09/2010
2Intravenous Immunoglobulins (IVIG)FDA Link
11/2016 - 01/2012
2Thalidomide (Thalomid)FDA Link
10/2016 - 01/2015
2Interleukin-10 (Interleukin 10)IBA
10/2016 - 01/2010
2Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2016 - 01/2009
2Messenger RNA (mRNA)IBA
01/2016 - 02/2005
2ChloridesIBA
10/2014 - 02/2006
2Creatine Kinase (Creatine Phosphokinase)IBA
01/2014 - 09/2011
2Vasopressins (Vasopressin)IBA
01/2014 - 04/2013
2anti-leucine-rich glioma-inactivated 1 autoantibodyIBA
11/2013 - 08/2012
2Dextran SulfateIBA
10/2013 - 01/2010
2Trastuzumab (Herceptin)FDA Link
11/2010 - 02/2010
2Interleukin-8 (Interleukin 8)IBA
01/2009 - 10/2005
2beta CateninIBA
11/2004 - 04/2003
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
03/2004 - 07/2003

Therapy/Procedure

16Therapeutics
11/2021 - 10/2005
11Drug Therapy (Chemotherapy)
11/2021 - 01/2002
4Neoadjuvant Therapy
02/2010 - 01/2002
2Conservative Treatment
08/2013 - 01/2003
2Enema (Enemas)
09/2010 - 02/2007
2Aftercare (After-Treatment)
10/2005 - 05/2003
2Radiotherapy
05/2005 - 03/2002